HIV Vaccine and Biomedical Prevention Research Project: IAVI ADVANCE (Accelerate the Development of Vaccines and New Technologies to Combat the AIDSEpidemic)

USAID provides support to the International AIDS Vaccine Initiative (IAVI) through a 5-year cooperative agreement to conduct preclinical and clinical HIV vaccine research and development (R&D) and increase the technical involvement, scientific leadership, and programmatic decision-making capacity of African scientists in biomedical HIV prevention.

The search for a safe and globally effective HIV vaccine is a long-term endeavor.

This cooperative agreement takes the unique circumstances of the epidemic in specific populations into consideration, ensuring an integrated and robust approach toward the discovery of an HIV vaccine.

The award specifically emphasizes: African-centered science; R&D capacity-building endeavors; Forming and optimizing existing and novel strategic partnerships; Achieving the goals of efficiency and sustainability through leveraging resources and cost sharing; and Broad sharing of data locally and internationally..